| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/25/2002 | EP1242584A2 Human kinases |
| 09/25/2002 | EP1242583A2 Human oxidoreductase proteins |
| 09/25/2002 | EP1242580A1 Methods and materials relating to semaphorin-like polypeptides and polynucleotides |
| 09/25/2002 | EP1242579A2 Th1 specific cd4 t cell lines and method for inducing them ex vivo |
| 09/25/2002 | EP1242578A1 Cell culture medim containing growth factors and l-glutamine |
| 09/25/2002 | EP1242577A1 Process for ex vivo formation of mammalian bone and uses thereof |
| 09/25/2002 | EP1242576A1 Stabilizing diluent for polypeptides and antigens |
| 09/25/2002 | EP1242459A1 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 09/25/2002 | EP1242458A2 Brain specific binding members |
| 09/25/2002 | EP1242456A2 Scfv antibodies against disease associated molecules |
| 09/25/2002 | EP1242449A1 Modified adenovirus fibre and uses |
| 09/25/2002 | EP1242448A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 09/25/2002 | EP1242129A2 Biological joint construct |
| 09/25/2002 | EP1242060A1 Treatment of metastatic disease |
| 09/25/2002 | EP1242050A2 Survivin promotion of angiogenesis |
| 09/25/2002 | EP1241939A1 Spore-like cells and uses thereof |
| 09/25/2002 | EP1241936A1 A method to produce cloned embryos and adults from cultured cells |
| 09/25/2002 | EP1241935A2 Methods for producing transgenic animals |
| 09/25/2002 | EP1241934A1 Melanocortin-4 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 09/25/2002 | EP1241933A1 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 09/25/2002 | EP1241931A1 Cloning pigs using donor cells or nuclei from differentiated cells and production of pluripotent porcine. |
| 09/25/2002 | EP1210379A4 Biodegradable poly(propylene fumarate) networks cross linked with poly(propylene fumarate)-diacrylate macromers |
| 09/25/2002 | EP1194463A4 Poly(propylene fumarate) cross linked with poly(ethylene glycol) |
| 09/25/2002 | EP1179176A4 Enriched antigen-specific t-cells, and related therapeutic and prophylactic compositions and methods |
| 09/25/2002 | EP1171006A4 Functionalized poly(propylene fumarate) and poly(propylene fumarate-co-ethylene glycol) |
| 09/25/2002 | EP1115852A4 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| 09/25/2002 | EP1060184A4 Best's macular dystrophy gene |
| 09/25/2002 | EP0989866B1 Wound dressing with biodegradable cell-anchoring layer |
| 09/25/2002 | EP0975765A4 Plant fatty acid epoxygenase genes and uses therefor |
| 09/25/2002 | EP0804591B1 Serum paraoxonase |
| 09/25/2002 | EP0696320B1 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 09/25/2002 | CN1371425A Plant gene expression controlled by constitutive plant V-ATPASE promoters |
| 09/25/2002 | CN1371421A Tankyrase 2 materials and methods |
| 09/25/2002 | CN1371420A Orynebacterium glutamicum genes encoding phosphoenolpyruvate sugar phosphotransferase system proteins |
| 09/25/2002 | CN1371416A Human CTLA-4 antibodies and their uses |
| 09/25/2002 | CN1371415A Fabrication of beta-pleated sheet proteins with specific binding properties |
| 09/25/2002 | CN1371390A Human G-protein coupled receptor |
| 09/25/2002 | CN1371389A 疫苗 Vaccine |
| 09/25/2002 | CN1371289A Gene therapy using TGF-beta |
| 09/25/2002 | CN1370783A Small molecular lung cancer antibody targeted immunotoxin and its prepn and use |
| 09/24/2002 | US6455755 Leukotriene B4 receptor transgenic mice |
| 09/24/2002 | US6455754 Screening for modulators of neuronal receptor binding activity; obtain animal model, incubate with modulator, monitor adjustments in neuronal activity |
| 09/24/2002 | US6455686 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 09/24/2002 | US6455683 Nucleotidesequences coding protein for use in the prevetion and treatment of infectious, inflammatory and allergic diseases |
| 09/24/2002 | US6455678 Human hematopoietic stem and progenitor cell antigen |
| 09/24/2002 | US6455676 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging |
| 09/24/2002 | US6455675 GA 20-oxidase gene sequences |
| 09/24/2002 | US6455674 Polypeptide for use in the diagnosis and treatment of tissue oxygenation defects |
| 09/24/2002 | US6455673 Polypeptide for use as vaccine in prevention of microorganismal infections |
| 09/24/2002 | US6455524 Medicament compositions based on anticholinergically-effective compounds and beta-mimetics |
| 09/24/2002 | US6455494 Use of p97 and iron binding proteins as diagnostic and therapeutic agents |
| 09/24/2002 | US6455312 Producing perennial grape embryonic culture by visibly identifying embryonic cells from first explant culture by color, transferring to second culture to proliferate, then identifying and transferring to third culture |
| 09/24/2002 | US6455311 Fabrication of vascularized tissue |
| 09/24/2002 | US6455306 Expanding culture of pure primitive hematopoieic cells in first bioreactor, culturing in second bioreactor to promote differentiation into erythroid cells, then culturing in third reactor to produce mature erythrocytes |
| 09/24/2002 | US6455305 Nucleotide sequence of gene involved in cancer; anticarcinogenic agents |
| 09/24/2002 | US6455300 Mammalian cell with steroid receptor response elements; for screening agonists and antagonists |
| 09/24/2002 | US6455299 Methods of use of viral vectors to deliver antigen to dendritic cells |
| 09/24/2002 | US6455298 Animal cells and processes for the replication of influenza viruses |
| 09/24/2002 | US6455296 Isolated gene coding polypeptide |
| 09/24/2002 | US6455291 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/24/2002 | US6455290 Tankyrase homolog protein (THP), nucleic acids, and methods related to the same |
| 09/24/2002 | US6455283 Amino acid sequence of polypeptide; for recombinant cell culture production of this growth factor; anticarcinogenic agents; wound healing agents |
| 09/24/2002 | US6455278 Nucleic acid which encodes protein of defined amino acid sequence involved in pain perception; analgesics |
| 09/24/2002 | US6455277 Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides |
| 09/24/2002 | US6455276 Human α4 receptor subunit of the GABA-A receptor |
| 09/24/2002 | US6455267 Methods and kits useful for determining the status of and detecting pancreatic B-cell associated autoimmune diseases |
| 09/24/2002 | US6455265 Preparing candidate immunogenic agents based on an envelope protein of a pathogenic strain, then selecting a modified polypeptide which induces an immune response against the immunodomnant region of the protein but not the host |
| 09/24/2002 | US6455264 Antibodies and diagnostic methods for the diagnosis of pestiviruses |
| 09/24/2002 | US6455247 Introducing library of randomized nucleic acids linked to secretion signal into cells, expressing nucleic acids to form peptides, and screening second cells which are co-cultured with first cells for altered phenotypes |
| 09/24/2002 | US6455044 5c8 antigen |
| 09/24/2002 | US6453683 Tapered slot cryopreservation system with controlled dendritic freezing front velocity |
| 09/23/2002 | CA2378494A1 Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase, and materials and methods for identification of inhibitors thereof |
| 09/20/2002 | CA2342376A1 A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 09/19/2002 | WO2002073204A2 Cell-based detection and differentiation of disease states |
| 09/19/2002 | WO2002073187A1 Method for generating replacement cells and/or tissues |
| 09/19/2002 | WO2002072872A2 System for screening fatty acid transport inhibitors, methods of use and modulators identified thereby |
| 09/19/2002 | WO2002072859A1 Process for producing oligosaccharide chains |
| 09/19/2002 | WO2002072851A2 Lentiviral packaging constructs |
| 09/19/2002 | WO2002072850A1 Activated dual specificity lymphocytes and their methods of use |
| 09/19/2002 | WO2002072844A1 Novel expression vectors |
| 09/19/2002 | WO2002072843A1 Novel vectors for animal cells and utilization thereof |
| 09/19/2002 | WO2002072841A1 Dna encoding hydantoinase, dna encoding n-carbamyl-l-amino acid hydrolase, recombinant dna, transformed cells, process for producing protein and process for producing optically active amino acid |
| 09/19/2002 | WO2002072837A1 Plant synthesizing copolyester from monomer derived from short-chain fatty acid and process for producing polyester |
| 09/19/2002 | WO2002072832A2 Therapeutic binding molecules |
| 09/19/2002 | WO2002072831A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/19/2002 | WO2002072830A2 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | WO2002072826A2 Neurotrophic factors |
| 09/19/2002 | WO2002072822A2 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 09/19/2002 | WO2002072808A1 Methods of screening for introduction of dna into a target cell |
| 09/19/2002 | WO2002072802A2 Live attenuated strains of prrs virus |
| 09/19/2002 | WO2002072800A1 Artificial dermis and production method therefor |
| 09/19/2002 | WO2002072799A1 Cd4+cd25+ regulatory t cells from human blood |
| 09/19/2002 | WO2002072798A1 Fas ligand-expressing hematopoietic cells for transplantation |
| 09/19/2002 | WO2002072797A2 Cell culture substrate and the use thereof |
| 09/19/2002 | WO2002072796A2 Continuous, normal human t-lymphocyte cell lines comprising a recombinant immune receptor with defined antigen specificity |
| 09/19/2002 | WO2002072794A2 Immunoglobulin superfamily proteins |
| 09/19/2002 | WO2002072790A2 Tsg101-gag interaction and use thereof |
| 09/19/2002 | WO2002072788A2 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 09/19/2002 | WO2002072769A2 Human serpin polypeptides |
| 09/19/2002 | WO2002072768A2 ISOGENIC ss-CATENIN CELL LINES, AND METHODS OF MAKING AND USING SAME |